| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10148555 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2019 | 5 Pages |
Abstract
NAFLD is common in Sri Lankan patients with T2DM and central and global obesity are significant associations. Use of pioglitazone seemed to be protective against the development of NAFLD. These findings underscore the need for weight management as a preventive measure of NAFLD in T2DM patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Herath Mudiyanselage Meththananda Herath, Iroshani Kodikara, Thilak Priyantha Weerarathna, Gayani Liyanage,